Fresenius Medical Care launches "Augmented Reality" for training on Kidney Replacement Therapy device
- None.
- None.
The introduction of Augmented Reality (AR) training by Fresenius Medical Care represents a significant advancement in medical technology applications, particularly in the field of nephrology and critical care nursing. The integration of AR into medical training methodologies could potentially revolutionize the way ICU staff are trained, offering a more interactive and immersive learning experience.
From a business perspective, this innovation may lead to improved operational efficiencies within hospitals. By shortening the learning curve for new staff and enhancing the proficiency of existing staff, AR could reduce the time and costs associated with training. Additionally, it may improve patient outcomes by ensuring that ICU personnel are better trained to operate kidney replacement therapy systems, which could lead to increased demand for Fresenius Medical Care's products and services.
The long-term implications could include the establishment of a new standard in medical training, potentially creating a competitive advantage for Fresenius Medical Care. However, the adoption rate and the effectiveness of the AR training program in improving patient care will be critical factors in determining its impact on the company's market position and financial performance.
The deployment of AR in ICU staff training by Fresenius Medical Care addresses a important pain point in healthcare: the shortage and high turnover of nursing staff. By simplifying the training process, the company is not only enhancing its value proposition to healthcare providers but also responding proactively to a workforce challenge that impacts the entire industry.
In terms of market impact, this innovation is likely to be viewed favorably by investors and healthcare providers alike. The ability to quickly and effectively train staff is a significant competitive differentiator. If the AR training program demonstrates a measurable impact on ICU efficiency and patient care quality, it could drive further investment into AR technologies within the healthcare sector, potentially leading to broader market shifts.
However, the cost of implementing such technologies and the scalability across different regions and hospital systems will be important considerations. The success of the limited launch and subsequent wider release will be key indicators of the program's viability and its potential influence on Fresenius Medical Care's stock performance.
- For the first time, Fresenius Medical Care develops and utilizes "Augmented Reality" (AR) to train medical staff in Intensive Care Units (ICUs)
- The new training application for ICU staff combines digital learning elements with real-life training on the Fresenius Medical Care Continuous Kidney Replacement Therapy system
- This learning experience reinforces initial training, a supplement to support new staff amidst the high fluctuation of specialists in intensive care nursing
BAD HOMBURG,
"We have a dedicated focus on leveraging advanced technology to develop and provide the most innovative technologies, engineered to facilitate and simplify the learning process. Our innovative solution is designed to ensure that nursing staff, particularly those in Intensive Care Units, are equipped with the knowledge needed to provide high-quality and exceptional patient care," says Dr. Katarzyna Mazur-Hofsäß, member of the Management Board of Fresenius Medical Care AG and responsible for Care Enablement, Fresenius Medical Care's MedTech segment.
The AR glasses allow for self-guided, on-demand education for critical care professionals. For example, users train how to set up the machine, how to activate the citrate pump or how to handle several system components through the AR training. The AR glasses provide access to the Augmented Reality learning program Ready4 multiFiltratePRO AR, which Fresenius Medical Care presented today at the International Symposium on Intensive Care and Emergency Medicine (ISICEM) in
The AR training application, Ready4 multiFiltratePRO AR, will be launched in select markets as early as Q2 2024 and subsequently made available to further countries in the company's
Nursing shortages in the ICU, in particular high staff turnover rates and staff taking on new tasks at short notice, are a significant concern in hospitals and healthcare systems worldwide. This training approach aims to address the challenges the industry is currently facing and to support the increasing demand for flexible, high-quality ongoing education to reinforce basic training.
Ready4 multiFiltratePRO AR has been specifically developed for use with the multiFiltratePRO, Fresenius Medical Care's Continuous Kidney Replacement Therapy system. Today, the multiFiltratePRO is used in more than 40 countries globally.
To learn more about the Ready4 multiFiltratePRO AR, please visit https://www.freseniusmedicalcare.com/en/ready4-multifiltratepro-ar.
About Fresenius Medical Care:
Fresenius Medical Care is the world's leading provider of products and services for individuals with renal diseases of which around 3.9 million patients worldwide regularly undergo dialysis treatment. Through its network of 4,000 dialysis clinics, Fresenius Medical Care provides dialysis treatments for approximately 332,000 patients around the globe and is the leading provider of dialysis products such as dialysis machines and dialyzers. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and on the New York Stock Exchange (FMS).
For more information visit the Company's website at www.freseniusmedicalcare.com.
Disclaimer:
This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to various factors, including, but not limited to, changes in business, economic and competitive conditions, legal changes, regulatory approvals, impacts related to COVID-19, results of clinical studies, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG's reports filed with the
Media contact
Christine Peters
T +49 160 60 66 770
christine.peters@freseniusmedicalcare.com
Contact for analysts and investors
Dr. Dominik Heger
T +49 6172 609 2601
dominik.heger@freseniusmedicalcare.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/fresenius-medical-care-launches-augmented-reality-for-training-on-kidney-replacement-therapy-device-302091941.html
SOURCE Fresenius Medical Care Holdings, Inc.
FAQ
What technology is Fresenius Medical Care utilizing to train ICU staff?
What is the name of the AR training application introduced by Fresenius Medical Care?
When will the Ready4 multiFiltratePRO AR be launched in select markets?
Which global event did Fresenius Medical Care present the Ready4 multiFiltratePRO AR at?
What is the main purpose of the AR training application for ICU staff?
